“The Health Insurance Portability and Accountability Act (HIPAA) of 1996 made it illegal to access personal health information for any reason other than health care delivery, operations, and reimbursement. health” (Shi & Singh, 2008, p. “HIPAA legislation imposed strict controls on the transfer of personally identifiable health information between two entities, provisions for disclosure of protected information, and criminal penalties for violations” (Clayton 2001). “HIPAA also imposes privacy requirements that govern the disclosure of patients' protected health information (PHI) placed in the medical record by doctors, nurses, and other health care providers. (Buck, 2011) Always remember that conversations about a patient's health care or treatment are a violation of HIPAA. “All personal health information is included in the privacy requirements. , for example: the past, present or future physical or mental health or condition of the patient; the provision of health care to the person, or past, present or future payment for the provision of health care to the person, and which identifies the person or for which there is a reasonable basis to believe that it can be used to identify the person. individual” (Buck, 2011). Other identifiable health information would be the patient's name, address, date of birth, and social security number (Keomouangchanh, 2011). (197 word count) There have been ethical issues surrounding the development and use of technology, which would consist of advancements, such as "when in vitro fertilization is applied in medical practice and leads to production of replacement embryos, the moral question is what to do with these embryos” (Shi & Singh, 2008, p. 182). As for the ethical dilemmas that come into play with "human genetic mapping, genetic cloning, stem cell research, and other areas of growing interest to scientists" (Shi & Singh, 2008, p. 182) . “Life-sustaining technology raises serious ethical questions, particularly in medical decisions regarding the continuation or cessation of mechanical support, particularly when a patient is in a permanent vegetative state” (Shi and Singh, 2008, p. 182). Healthcare budgets are limited around the world, making it difficult to make progress and even more difficult to develop progress with constraints. Which brings us back to “social, ethical and legal constraints, public and private insurers are faced with the problem of deciding whether or not to cover new treatments” 188. Likewise, what was mentioned before the decisions on “new techniques such as intracytoplasmic sperm injection, in vitro fertilization (ICSIIVF), new predictive molecular genetic tests for hereditary breast cancer, and new drugs such as sildenafil (Viagra) for sexual dysfunction” (Giacomini, 2005).